Multiple-Dose, Dose-Escalation Study to Evaluate the Safety/Tolerability and Pharmacokinetics of FP-045
Clinical trial NCT03686930 · COMPLETED
Trial details
- NCT number
- NCT03686930
- Sponsor
- Foresee Pharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-22
- Primary completion
- 2018-05-27
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.